{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:09:35Z","timestamp":1794622175817,"version":"4.9.1"},"reference-count":60,"publisher":"Cambridge University Press (CUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Occlutech Atrial Flow Regulator is a self-expandable double-disc nitinol device with a central fenestration designed to create a calibrated communication across the interatrial septum. It has been used in adult patients with heart failure and pulmonary hypertension. Its use in the paediatric population or adults with CHD has been published in several case reports and case series. This study aims to review the potential, efficacy, and safety of this device in the paediatric and adult populations living with CHD, as well as in paediatric patients with pulmonary hypertension or advanced heart failure.<\/jats:p>","DOI":"10.1017\/s1047951125109463","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:14:07Z","timestamp":1757574847000},"page":"1975-1981","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Use of atrial flow regulator device in children and patients with CHD: a literature review"],"prefix":"10.1017","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1947-9677","authenticated-orcid":false,"given":"Fausto","family":"Frazzetto","sequence":"first","affiliation":[{"name":"IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-2745","authenticated-orcid":false,"given":"Enrico","family":"Piccinelli","sequence":"additional","affiliation":[{"name":"IRCCS"},{"name":"Politecnico di Torino"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-1134","authenticated-orcid":false,"given":"Mara","family":"Pilati","sequence":"additional","affiliation":[{"name":"IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Rebonato","sequence":"additional","affiliation":[{"name":"IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-0108","authenticated-orcid":false,"given":"Gianfranco","family":"Butera","sequence":"additional","affiliation":[{"name":"IRCCS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"S1047951125109463_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.03.048"},{"key":"S1047951125109463_ref51","first-page":"584","article-title":"Results of transcatheter Fontan fenestration to treat protein losing enteropathy","volume":"69","author":"Vyas","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"S1047951125109463_ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1332395"},{"key":"S1047951125109463_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90814-C"},{"key":"S1047951125109463_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.02.046"},{"key":"S1047951125109463_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09787-0"},{"key":"S1047951125109463_ref57","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2174\/138161206776361309","article-title":"The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices","volume":"12","author":"Andreas","year":"2006","journal-title":"Curr Pharm Des"},{"key":"S1047951125109463_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00016-2"},{"key":"S1047951125109463_ref49","first-page":"936","article-title":"Percutaneous Transcatheter Communication Between the Pulmonary Artery and Atrium Following an Extra-Cardiac Fontan: An Alternative Approach to Fenestration Avoiding Conduit Perforation","volume":"71","author":"Mehta","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"S1047951125109463_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.03.198"},{"key":"S1047951125109463_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00546-8"},{"key":"S1047951125109463_ref56","doi-asserted-by":"publisher","DOI":"10.1177\/1753944720919577"},{"key":"S1047951125109463_ref55","first-page":"1021","article-title":"Transcatheter removal of atrial septal stent placed to decompress left atrium with VA ECMO","volume":"85","author":"Veeram Reddy","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"S1047951125109463_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2007.10.004"},{"key":"S1047951125109463_ref12","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.111"},{"key":"S1047951125109463_ref35","doi-asserted-by":"publisher","DOI":"10.1177\/2045894018776518"},{"key":"S1047951125109463_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2023.101209"},{"key":"S1047951125109463_ref14","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2021.10.n1612"},{"key":"S1047951125109463_ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2011.00488.x"},{"key":"S1047951125109463_ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.174287"},{"key":"S1047951125109463_ref7","unstructured":"7. The Prophet Trial-Pilot study to assess the safety and efficacy of a novel Atrial Flow Regulator (AFR) in patients with pulmonary hypertension (AFR-Prophet). Clinicaltrials.gov identifier: NCT03022851. Accessed January 10, 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03022851"},{"key":"S1047951125109463_ref54","article-title":"Feasibility, safety, and efficacy of Atrial FlowRegulator in children under 10 kg","author":"Bautista-Rodriguez","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"S1047951125109463_ref29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01916-2018"},{"key":"S1047951125109463_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2021.06.002"},{"key":"S1047951125109463_ref37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.7.2028"},{"key":"S1047951125109463_ref46","first-page":"66","article-title":"Atrial flow regulator for failing Fontan circulation: An initial European experience","volume":"27","author":"Manuri","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"S1047951125109463_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02522-5"},{"key":"S1047951125109463_ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2119"},{"key":"S1047951125109463_ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2020.11.006"},{"key":"S1047951125109463_ref21","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.8.876"},{"key":"S1047951125109463_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.023"},{"key":"S1047951125109463_ref45","doi-asserted-by":"publisher","DOI":"10.1111\/aor.12011"},{"key":"S1047951125109463_ref3","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.2019.0016"},{"key":"S1047951125109463_ref6","unstructured":"6. Atrial flow regulator in heart failure (PROLONGER). Clinicaltrials.gov identifier: NCT04334694. Accessed January 10, 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04334694"},{"key":"S1047951125109463_ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1073336"},{"key":"S1047951125109463_ref27","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000329"},{"key":"S1047951125109463_ref38","first-page":"1145","article-title":"Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension","volume":"90","author":"Rajeshkumar","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"S1047951125109463_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(02)03677-9"},{"key":"S1047951125109463_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.03.003"},{"key":"S1047951125109463_ref31","first-page":"3618","article-title":"ESC\/ERS Scientific Document Group, 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)","volume":"43","author":"Marc","year":"2022","journal-title":"Eur Heart J"},{"key":"S1047951125109463_ref42","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1986.61.5.1634"},{"key":"S1047951125109463_ref60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/apc.APC_52_20","article-title":"Transcatheter reduction in size of large undesirable fenestrations following extracardiac conduit Fontan surgery with off-label use of Occlutech atrial flow regulator","volume":"13","author":"Sonawane","year":"2020","journal-title":"Ann Pediatr Cardiol"},{"key":"S1047951125109463_ref48","doi-asserted-by":"crossref","first-page":"668","DOI":"10.33963\/v.phj.100568","article-title":"Creation of the secondary fenestration in the inferior vena cava stump with the Occlutech Atrial Flow Regulator implantation in a Fontan patient","volume":"82","author":"Rafa\u0142","year":"2024","journal-title":"Kardiol Pol"},{"key":"S1047951125109463_ref26","doi-asserted-by":"publisher","DOI":"10.1017\/S104795112300046X"},{"key":"S1047951125109463_ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-018-1996-3"},{"key":"S1047951125109463_ref13","unstructured":"13. The AFteR registry\u2013follow-up study to monitor the efficacy and safety of the Occlutech AFR in heart failure patients. Clinicaltrials.gov identifier: NCT04405583. Accessed January 10, 2023."},{"key":"S1047951125109463_ref40","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307467"},{"key":"S1047951125109463_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2022.05.010"},{"key":"S1047951125109463_ref8","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"S1047951125109463_ref5","first-page":"E830","article-title":"Atrial flow regulator for drug-resistant pulmonary hypertension in a young child","volume":"97","author":"Vanhie","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"S1047951125109463_ref33","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300462"},{"key":"S1047951125109463_ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003025"},{"key":"S1047951125109463_ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.104638"},{"key":"S1047951125109463_ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2045894021989966"},{"key":"S1047951125109463_ref47","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951121000731"},{"key":"S1047951125109463_ref19","doi-asserted-by":"publisher","DOI":"10.4065\/70.7.634"},{"key":"S1047951125109463_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.051"},{"key":"S1047951125109463_ref32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00694.2009"},{"key":"S1047951125109463_ref59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2018.05.009","article-title":"Anticoagulation during ECMO in neonatal and paediatric patients","volume":"173","author":"Rebecca","year":"2019","journal-title":"Thromb Res"},{"key":"S1047951125109463_ref28","doi-asserted-by":"publisher","DOI":"10.1002\/j.2040-4603.2021.tb00176.x"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951125109463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:59:53Z","timestamp":1779425993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951125109463\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1047951125109463"],"URL":"https:\/\/doi.org\/10.1017\/s1047951125109463","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}